Single Injection of Cross-Linked Hyaluronate in Knee Osteoarthritis: A 52-Week Double-Blind Randomized Controlled Trial

Background: to compare the 52-week effectiveness and safety between HYAJOINT Plus (HJP) and Durolane in knee osteoarthritis (OA) treatment. Methods: consecutive patients received a single injection of 3 mL HJP or Durolane. The primary outcome was a visual analog scale (VAS) pain measurement at 26 weeks post-injection. Secondary outcomes included other clinical, satisfaction, and safety assessments for 52 weeks. Results: 142 patients were equally randomized. At week 26, the HJP group had less VAS pain than the Durolane group (18.1 ± 9.5 versus 24.4 ± 14.0, p = 0.001). Both groups showed improvement in their VAS pain and stiffness scores, and Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain and total scores for 52 weeks after injection (p < 0.001). However, the HJP group showed lower VAS pain and stiffness scores, reduced WOMAC pain and stiffness scores, a shorter Timed “Up & Go” (TUG) time, and a higher satisfaction score than the Durolane group for 39 weeks (p < 0.05). Only mild and self-limited adverse events occurred (40.8%). Conclusion: While a single injection of either HJP or Durolane is safe and effective for at least 52 weeks, HJP provided superior improvement in terms of VAS pain and stiffness scores, WOMAC pain and stiffness scores, and satisfaction score within 39 weeks of treatment.

[1]  Seulbi Lee,et al.  Self-assembled hyaluronic acid nanoparticles for osteoarthritis treatment. , 2021, Biomaterials.

[2]  D. Haupenthal,et al.  Intra‐articular treatment with hyaluronic acid associated with gold nanoparticles in a mechanical osteoarthritis model in Wistar rats , 2021, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[3]  F. Lin,et al.  Hyaluronic Acid Loaded with Cerium Oxide Nanoparticles as Antioxidant in Hydrogen Peroxide Induced Chondrocytes Injury: An In Vitro Osteoarthritis Model , 2020, Molecules.

[4]  Ilker S. Bayer.  Hyaluronic Acid and Controlled Release: A Review , 2020, Molecules.

[5]  M. Samiei,et al.  The Potential Applications of Hyaluronic Acid Hydrogels in Biomedicine , 2019, Drug Research.

[6]  E. Kon,et al.  Platelet-Rich Plasma Versus Hyaluronic Acid Injections for the Treatment of Knee Osteoarthritis: Results at 5 Years of a Double-Blind, Randomized Controlled Trial , 2018, The American journal of sports medicine.

[7]  S. Petterson,et al.  Single intra-articular injection of lightly cross-linked hyaluronic acid reduces knee pain in symptomatic knee osteoarthritis: a multicenter, double-blind, randomized, placebo-controlled trial , 2018, Knee Surgery, Sports Traumatology, Arthroscopy.

[8]  R. Leighton,et al.  Systematic clinical evidence review of NASHA (Durolane hyaluronic acid) for the treatment of knee osteoarthritis , 2018, Open access rheumatology : research and reviews.

[9]  Huey-Shyan Lin,et al.  Comparison of Single Intra-Articular Injection of Novel Hyaluronan (HYA-JOINT Plus) with Synvisc-One for Knee Osteoarthritis: A Randomized, Controlled, Double-Blind Trial of Efficacy and Safety , 2017, The Journal of bone and joint surgery. American volume.

[10]  M. H. Santana,et al.  Randomized controlled trial comparing hyaluronic acid, platelet-rich plasma and the combination of both in the treatment of mild and moderate osteoarthritis of the knee , 2016, Journal of stem cells & regenerative medicine.

[11]  R. Altman,et al.  Product Differences in Intra-articular Hyaluronic Acids for Osteoarthritis of the Knee , 2016, The American journal of sports medicine.

[12]  J. Reginster,et al.  Efficacy and safety of hyaluronic acid in the management of osteoarthritis: Evidence from real-life setting trials and surveys. , 2016, Seminars in arthritis and rheumatism.

[13]  Brian J Cole,et al.  Is Local Viscosupplementation Injection Clinically Superior to Other Therapies in the Treatment of Osteoarthritis of the Knee: A Systematic Review of Overlapping Meta-analyses. , 2015, Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association.

[14]  J. Jerosch,et al.  Consensus statement on viscosupplementation with hyaluronic acid for the management of osteoarthritis. , 2015, Seminars in arthritis and rheumatism.

[15]  J. García-Sancho,et al.  Treatment of Knee Osteoarthritis With Allogeneic Bone Marrow Mesenchymal Stem Cells: A Randomized Controlled Trial , 2015, Transplantation.

[16]  S Lohmander,et al.  OARSI guidelines for the non-surgical management of knee osteoarthritis. , 2014, Osteoarthritis and cartilage.

[17]  G. Orive,et al.  Comparison of intra-articular injections of plasma rich in growth factors (PRGF-Endoret) versus Durolane hyaluronic acid in the treatment of patients with symptomatic osteoarthritis: a randomized controlled trial. , 2013, Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association.

[18]  Greg A. Brown.  AAOS clinical practice guideline: treatment of osteoarthritis of the knee: evidence-based guideline, 2nd edition. , 2013, The Journal of the American Academy of Orthopaedic Surgeons.

[19]  C. Cooper,et al.  Epidemiology and burden of osteoarthritis. , 2013, British medical bulletin.

[20]  L. Kuo,et al.  Pain in patients with equal radiographic grades of osteoarthritis in both knees: the value of gray scale ultrasound. , 2012, Osteoarthritis and cartilage.

[21]  Gordon Guyatt,et al.  American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee , 2012, Arthritis care & research.

[22]  D. Uebelhart,et al.  Efficacy evaluation of highly purified intra-articular hyaluronic acid (Sinovial(®)) vs hylan G-F20 (Synvisc(®)) in the treatment of symptomatic knee osteoarthritis. A double-blind, controlled, randomized, parallel-group non-inferiority study. , 2011, Osteoarthritis and cartilage.

[23]  Raveendhara R. Bannuru,et al.  Therapeutic trajectory following intra-articular hyaluronic acid injection in knee osteoarthritis--meta-analysis. , 2010, Osteoarthritis and cartilage.

[24]  F. Luyten,et al.  Single, intra-articular treatment with 6 ml hylan G-F 20 in patients with symptomatic primary osteoarthritis of the knee: a randomised, multicentre, double-blind, placebo controlled trial , 2009, Annals of the rheumatic diseases.

[25]  N. Bellamy,et al.  Viscosupplementation for the treatment of osteoarthritis of the knee. , 2006, The Cochrane database of systematic reviews.

[26]  M. Dougados,et al.  EULAR report on the use of ultrasonography in painful knee osteoarthritis. Part 1: Prevalence of inflammation in osteoarthritis , 2005, Annals of the rheumatic diseases.

[27]  T. Schnitzer,et al.  Efficacy and safety of a single intra-articular injection of non-animal stabilized hyaluronic acid (NASHA) in patients with osteoarthritis of the knee. , 2004, Osteoarthritis and cartilage.

[28]  R. Coutts,et al.  Viscosupplementation for osteoarthritis of the knee. , 2004, Orthopedics.

[29]  E. Vignon,et al.  Factors predicting long-term efficacy of Hylan GF-20 viscosupplementation in knee osteoarthritis. , 2003, Joint, bone, spine : revue du rhumatisme.

[30]  A. Davis,et al.  The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC): a review of its utility and measurement properties. , 2001, Arthritis and rheumatism.

[31]  H. Bliddal,et al.  Guidance by ultrasound of intra-articular injections in the knee and hip joints. , 2001, Osteoarthritis and cartilage.

[32]  P. Burton,et al.  Extending the simple linear regression model to account for correlated responses: an introduction to generalized estimating equations and multi-level mixed modelling. , 1998, Statistics in medicine.

[33]  W. Olszynski,et al.  Viscosupplementation with hylan for the treatment of osteoarthritis: findings from clinical practice in Canada. , 1996, The Journal of rheumatology.

[34]  Diane Podsiadlo,et al.  The Timed “Up & Go”: A Test of Basic Functional Mobility for Frail Elderly Persons , 1991, Journal of the American Geriatrics Society.

[35]  R. Moskowitz,et al.  Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. , 1986, Arthritis and rheumatism.

[36]  R W Bohannon,et al.  Decrease in timed balance test scores with aging. , 1984, Physical therapy.

[37]  M. Yeh,et al.  Intra-articular Injection of Platelet-Rich Plasma Is Superior to Hyaluronic Acid or Saline Solution in the Treatment of Mild to Moderate Knee Osteoarthritis: A Randomized, Double-Blind, Triple-Parallel, Placebo-Controlled Clinical Trial. , 2019, Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association.

[38]  N. Arden,et al.  NASHA hyaluronic acid vs. methylprednisolone for knee osteoarthritis: a prospective, multi-centre, randomized, non-inferiority trial. , 2014, Osteoarthritis and cartilage.